ALEXANDRIA, Va., July 21 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'FOTIVDA (TIVOZANIB )' in its latest official gazette. The trademark application with the serial number 85849026 was filed on Feb. 13, 2013.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for the treatment of cancer, namely, pharmaceutical preparations containing tivozanib hydrochloride
International/US Class(es): 5
Mark Drawing Code: 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)
Current Owner(s): AVEO Pharmaceuticals, Inc. One Marina Park Drive, 12th Floor Boston MA Massachusetts 02210 3 CORPORATION
Disclaimer: Curated by HT Syndication....